🇺🇸 FDA
Patent

US 11925689

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

granted A61KA61K38/09A61K47/59

Quick answer

US patent 11925689 (Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/09, A61K47/59, A61P, A61P35/00